$0.133000
0.00191.45%
At close: -
$0.129900
-0.0031-2.33%
After Hours: 4:06 PM EDT
Comments
Loading...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock, Analyst Ratings, Price Targets, Forecasts
Tonix Pharmaceuticals Holding Corp has a consensus price target of $4.87 based on the ratings of 3 analysts. The high is $11 issued by Alliance Global Partners on July 22, 2024. The low is $0.6 issued by Noble Capital Markets on April 18, 2022. The 3 most-recent analyst ratings were released by Alliance Global Partners, Dawson James, and Alliance Global Partners on July 22, 2024, February 28, 2024, and August 1, 2023, respectively. With an average price target of $7.33 between Alliance Global Partners, Dawson James, and Alliance Global Partners, there's an implied 5545.37% upside for Tonix Pharmaceuticals Holding Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Dawson James
Noble Capital Markets
1calculated from analyst ratings
Analyst Ratings for Tonix Pharmaceuticals
Data brought to you by Benzinga APIs
FAQ
What is the target price for Tonix Pharmaceuticals (TNXP) stock?
The latest price target for Tonix Pharmaceuticals (NASDAQ:TNXP) was reported by Alliance Global Partners on July 22, 2024. The analyst firm set a price target for $11.00 expecting TNXP to rise to within 12 months (a possible 8368.05% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tonix Pharmaceuticals (TNXP)?
The latest analyst rating for Tonix Pharmaceuticals (NASDAQ:TNXP) was provided by Alliance Global Partners, and Tonix Pharmaceuticals maintained their buy rating.
When was the last upgrade for Tonix Pharmaceuticals (TNXP)?
There is no last upgrade for Tonix Pharmaceuticals
When was the last downgrade for Tonix Pharmaceuticals (TNXP)?
There is no last downgrade for Tonix Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Tonix Pharmaceuticals (TNXP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tonix Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tonix Pharmaceuticals was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Tonix Pharmaceuticals (TNXP) correct?
While ratings are subjective and will change, the latest Tonix Pharmaceuticals (TNXP) rating was a maintained with a price target of $6.00 to $11.00. The current price Tonix Pharmaceuticals (TNXP) is trading at is $0.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.